444 related articles for article (PubMed ID: 25976317)
1. Transformation of acidic poorly water soluble drugs into ionic liquids.
Balk A; Wiest J; Widmer T; Galli B; Holzgrabe U; Meinel L
Eur J Pharm Biopharm; 2015 Aug; 94():73-82. PubMed ID: 25976317
[TBL] [Abstract][Full Text] [Related]
2. 'Pro et contra' ionic liquid drugs - Challenges and opportunities for pharmaceutical translation.
Balk A; Holzgrabe U; Meinel L
Eur J Pharm Biopharm; 2015 Aug; 94():291-304. PubMed ID: 26070389
[TBL] [Abstract][Full Text] [Related]
3. Spray Encapsulation as a Formulation Strategy for Drug-Based Room Temperature Ionic Liquids: Exploiting Drug-Polymer Immiscibility to Enable Processing for Solid Dosage Forms.
Stocker MW; Healy AM; Ferguson S
Mol Pharm; 2020 Sep; 17(9):3412-3424. PubMed ID: 32852215
[TBL] [Abstract][Full Text] [Related]
4. Lidocaine self-sacrificially improves the skin permeation of the acidic and poorly water-soluble drug etodolac via its transformation into an ionic liquid.
Miwa Y; Hamamoto H; Ishida T
Eur J Pharm Biopharm; 2016 May; 102():92-100. PubMed ID: 26945484
[TBL] [Abstract][Full Text] [Related]
5. Transformation of poorly water-soluble drugs into lipophilic ionic liquids enhances oral drug exposure from lipid based formulations.
Sahbaz Y; Williams HD; Nguyen TH; Saunders J; Ford L; Charman SA; Scammells PJ; Porter CJ
Mol Pharm; 2015 Jun; 12(6):1980-91. PubMed ID: 25905624
[TBL] [Abstract][Full Text] [Related]
6. Ionic liquid versus prodrug strategy to address formulation challenges.
Balk A; Widmer T; Wiest J; Bruhn H; Rybak JC; Matthes P; Müller-Buschbaum K; Sakalis A; Lühmann T; Berghausen J; Holzgrabe U; Galli B; Meinel L
Pharm Res; 2015 Jun; 32(6):2154-67. PubMed ID: 25534684
[TBL] [Abstract][Full Text] [Related]
7. Amino acids as co-amorphous stabilizers for poorly water soluble drugs--Part 1: preparation, stability and dissolution enhancement.
Löbmann K; Grohganz H; Laitinen R; Strachan C; Rades T
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):873-81. PubMed ID: 23537574
[TBL] [Abstract][Full Text] [Related]
8. Solid molecular dispersions of poorly water-soluble drugs in poly(2-hydroxyethyl methacrylate) hydrogels.
Zahedi P; Lee PI
Eur J Pharm Biopharm; 2007 Mar; 65(3):320-8. PubMed ID: 17182231
[TBL] [Abstract][Full Text] [Related]
9. Encapsulation of poorly water-soluble drugs into organic nanotubes for improving drug dissolution.
Moribe K; Makishima T; Higashi K; Liu N; Limwikrant W; Ding W; Masuda M; Shimizu T; Yamamoto K
Int J Pharm; 2014 Jul; 469(1):190-6. PubMed ID: 24746412
[TBL] [Abstract][Full Text] [Related]
10. Preparation of an amorphous sodium furosemide salt improves solubility and dissolution rate and leads to a faster Tmax after oral dosing to rats.
Nielsen LH; Gordon S; Holm R; Selen A; Rades T; Müllertz A
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):942-51. PubMed ID: 24075980
[TBL] [Abstract][Full Text] [Related]
11. A novel strategy to design sustained-release poorly water-soluble drug mesoporous silica microparticles based on supercritical fluid technique.
Li-Hong W; Xin C; Hui X; Li-Li Z; Jing H; Mei-Juan Z; Jie L; Yi L; Jin-Wen L; Wei Z; Gang C
Int J Pharm; 2013 Sep; 454(1):135-42. PubMed ID: 23871738
[TBL] [Abstract][Full Text] [Related]
12. Effect of water soluble carrier on dissolution profiles of diclofenac sodium.
Cwiertnia B
Acta Pol Pharm; 2013; 70(4):721-6. PubMed ID: 23923395
[TBL] [Abstract][Full Text] [Related]
13. Effect of the solid-dispersion method on the solubility and crystalline property of tacrolimus.
Joe JH; Lee WM; Park YJ; Joe KH; Oh DH; Seo YG; Woo JS; Yong CS; Choi HG
Int J Pharm; 2010 Aug; 395(1-2):161-6. PubMed ID: 20580799
[TBL] [Abstract][Full Text] [Related]
14. To enhance dissolution rate of poorly water-soluble drugs: glucosamine hydrochloride as a potential carrier in solid dispersion formulations.
Al-Hamidi H; Edwards AA; Mohammad MA; Nokhodchi A
Colloids Surf B Biointerfaces; 2010 Mar; 76(1):170-8. PubMed ID: 19945828
[TBL] [Abstract][Full Text] [Related]
15. Carboxylated mesoporous carbon microparticles as new approach to improve the oral bioavailability of poorly water-soluble carvedilol.
Zhang Y; Zhi Z; Li X; Gao J; Song Y
Int J Pharm; 2013 Sep; 454(1):403-11. PubMed ID: 23850816
[TBL] [Abstract][Full Text] [Related]
16. Ionic liquids in pharmaceutical applications.
Marrucho IM; Branco LC; Rebelo LP
Annu Rev Chem Biomol Eng; 2014; 5():527-46. PubMed ID: 24910920
[TBL] [Abstract][Full Text] [Related]
17. Tailor-made release triggering from hot-melt extruded complexes of basic polyelectrolyte and poorly water-soluble drugs.
Kindermann C; Matthée K; Strohmeyer J; Sievert F; Breitkreutz J
Eur J Pharm Biopharm; 2011 Oct; 79(2):372-81. PubMed ID: 21596136
[TBL] [Abstract][Full Text] [Related]
18. Diclofenac salts, part 7: are the pharmaceutical salts with aliphatic amines stable?
Fini A; Cavallari C; Bassini G; Ospitali F; Morigi R
J Pharm Sci; 2012 Sep; 101(9):3157-68. PubMed ID: 22234897
[TBL] [Abstract][Full Text] [Related]
19. An investigation into the influence of counterion on the properties of some amorphous organic salts.
Towler CS; Li T; Wikström H; Remick DM; Sanchez-Felix MV; Taylor LS
Mol Pharm; 2008; 5(6):946-55. PubMed ID: 19434850
[TBL] [Abstract][Full Text] [Related]
20. Salt screening and characterization for poorly soluble, weak basic compounds: case study albendazole.
Paulekuhn GS; Dressman JB; Saal C
Pharmazie; 2013 Jul; 68(7):555-64. PubMed ID: 23923637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]